Cargando…

Mechanistic and Biomarker Studies to Demonstrate Immune Tolerance in Multiple Sclerosis

The induction of specific immunological tolerance represents an important therapeutic goal for multiple sclerosis and other autoimmune diseases. Sound knowledge of the target antigens, the underlying pathomechanisms of the disease and the presumed mechanisms of action of the respective tolerance-ind...

Descripción completa

Detalles Bibliográficos
Autores principales:	Docampo, María José, Lutterotti, Andreas, Sospedra, Mireia, Martin, Roland
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8766750/ https://www.ncbi.nlm.nih.gov/pubmed/35069562 http://dx.doi.org/10.3389/fimmu.2021.787498

Ejemplares similares

Antigen-Specific Immune Tolerance in Multiple Sclerosis—Promising Approaches and How to Bring Them to Patients
por: Lutterotti, Andreas, et al.
Publicado: (2021)

T-Cell Specificity Influences Disease Heterogeneity in Multiple Sclerosis
por: Cruciani, Carolina, et al.
Publicado: (2021)

Detailed Characterization of T Cell Receptor Repertoires in Multiple Sclerosis Brain Lesions
por: Planas, Raquel, et al.
Publicado: (2018)

Characterization of Antigen-Induced CD4+ T-Cell Senescence in Multiple Sclerosis
por: Tomas-Ojer, Paula, et al.
Publicado: (2022)

Long-term safety and efficacy of natalizumab in relapsing-remitting multiple sclerosis: impact on quality of life
por: Planas, Raquel, et al.
Publicado: (2014)

Brain Citrullination Patterns and T Cell Reactivity of Cerebrospinal Fluid-Derived CD4(+) T Cells in Multiple Sclerosis
por: Faigle, Wolfgang, et al.
Publicado: (2019)

NK Cells and Innate-Like T Cells After Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis
por: Ruder, Josefine, et al.
Publicado: (2021)

Comparative Analysis of T-Cell Responses to Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein in Inflammatory Demyelinating Central Nervous System Diseases
por: Hofer, Livia Sophie, et al.
Publicado: (2020)

Basic CSF parameters and MRZ reaction help in differentiating MOG antibody-associated autoimmune disease versus multiple sclerosis
por: Vlad, Benjamin, et al.
Publicado: (2023)

Adaptive Features of Natural Killer Cells in Multiple Sclerosis
por: Moreira, Antía, et al.
Publicado: (2019)

Latitude, Vitamin D, Melatonin, and Gut Microbiota Act in Concert to Initiate Multiple Sclerosis: A New Mechanistic Pathway
por: Ghareghani, Majid, et al.
Publicado: (2018)

Memory B Cells Activate Brain-Homing, Autoreactive CD4(+) T Cells in Multiple Sclerosis
por: Jelcic, Ivan, et al.
Publicado: (2018)

CD8(+) T-Cells as Immune Regulators of Multiple Sclerosis
por: Sinha, Sushmita, et al.
Publicado: (2015)

Central role of Th2/Tc2 lymphocytes in pattern II multiple sclerosis lesions
por: Planas, Raquel, et al.
Publicado: (2015)

Biomarkers in Multiple Sclerosis
por: Martin, Roland, et al.
Publicado: (2006)

Altered CSF Albumin Quotient Links Peripheral Inflammation and Brain Damage in MS
por: Puthenparampil, Marco, et al.
Publicado: (2021)

Detection of Glycan Shedding in the Blood: New Class of Multiple Sclerosis Biomarkers?
por: DellaValle, Brian, et al.
Publicado: (2018)

Live Imaging of Immune Responses in Experimental Models of Multiple Sclerosis
por: Rossi, Barbara, et al.
Publicado: (2016)

Common Peripheral Immunity Mechanisms in Multiple Sclerosis and Alzheimer's Disease
por: Rossi, Barbara, et al.
Publicado: (2021)

Association of the retinal vasculature, intrathecal immunity, and disability in multiple sclerosis
por: Noll, Christina, et al.
Publicado: (2022)

Immune cells transcriptome-based drug repositioning for multiple sclerosis
por: Yin, Xinyue, et al.
Publicado: (2022)

HLA-DR15 Molecules Jointly Shape an Autoreactive T Cell Repertoire in Multiple Sclerosis
por: Wang, Jian, et al.
Publicado: (2020)

MX2: Identification and systematic mechanistic analysis of a novel immune-related biomarker for systemic lupus erythematosus
por: Meng, Xiang-Wen, et al.
Publicado: (2022)

Multiple Tolerization Subtractive Immunization (MTSI) Protocol: Effects on Mice and Monoclonal Antibody Specificity
por: de Lima Fontes, Marina, et al.
Publicado: (2021)

Searching for the Transcriptomic Signature of Immune Tolerance Induction—Biomarkers of Safety and Functionality for Tolerogenic Dendritic Cells and Regulatory Macrophages
por: Navarro-Barriuso, Juan, et al.
Publicado: (2018)

Editorial: Brain-Targeted Autoimmunity: Beyond Multiple Sclerosis
por: Nataf, Serge, et al.
Publicado: (2021)

Molecular signature associated with cladribine treatment in patients with multiple sclerosis
por: Fissolo, Nicolas, et al.
Publicado: (2023)

Natalizumab in Multiple Sclerosis Treatment: From Biological Effects to Immune Monitoring
por: Khoy, Kathy, et al.
Publicado: (2020)

Editorial: Environmental factors influencing the immune functions during multiple sclerosis
por: Smolders, Joost, et al.
Publicado: (2023)

Understanding humoral immunity and multiple sclerosis severity in Black, and Latinx patients
por: Telesford, Kiel M., et al.
Publicado: (2023)

A Case for Antibodies as Mechanistic Correlates of Immunity in Tuberculosis
por: Kawahara, Jeffrey Y., et al.
Publicado: (2019)

Mucosal-Associated Invariant T Cells in Multiple Sclerosis: The Jury is Still Out
por: Treiner, Emmanuel, et al.
Publicado: (2015)

Cerebrospinal fluid inflammatory biomarkers for disease progression in Alzheimer’s disease and multiple sclerosis: a systematic review
por: Temmerman, Joke, et al.
Publicado: (2023)

Blood Levels of Co-inhibitory-Receptors: A Biomarker of Disease Prognosis in Multiple Sclerosis
por: Lavon, Iris, et al.
Publicado: (2019)

EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-γ and IL-2
por: Lünemann, Jan D., et al.
Publicado: (2008)

MAP7 and MUCL1 Are Biomarkers of Vitamin D3-Induced Tolerogenic Dendritic Cells in Multiple Sclerosis Patients
por: Navarro-Barriuso, Juan, et al.
Publicado: (2019)

Dimethyl fumarate-related immune and transcriptional signature is associated with clinical response in multiple sclerosis-treated patients
por: Sánchez-Sanz, Alicia, et al.
Publicado: (2023)

Baseline Inflammatory Status Reveals Dichotomic Immune Mechanisms Involved In Primary-Progressive Multiple Sclerosis Pathology
por: Fernández-Velasco, José I., et al.
Publicado: (2022)

Treg: tolerance vs immunity
por: Biswas, Moanaro, et al.
Publicado: (2015)

Potential of PINK1 and PARKIN Proteins as Biomarkers for Active Multiple Sclerosis: A Japanese Cohort Study
por: Cossu, Davide, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_78fhur0t87t4eq552e7n4c4de6